These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2726 related articles for article (PubMed ID: 32094589)
1. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Letko M; Marzi A; Munster V Nat Microbiol; 2020 Apr; 5(4):562-569. PubMed ID: 32094589 [TBL] [Abstract][Full Text] [Related]
2. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. Wan Y; Shang J; Graham R; Baric RS; Li F J Virol; 2020 Mar; 94(7):. PubMed ID: 31996437 [TBL] [Abstract][Full Text] [Related]
3. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2. Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139 [TBL] [Abstract][Full Text] [Related]
4. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. Liu Z; Xiao X; Wei X; Li J; Yang J; Tan H; Zhu J; Zhang Q; Wu J; Liu L J Med Virol; 2020 Jun; 92(6):595-601. PubMed ID: 32100877 [TBL] [Abstract][Full Text] [Related]
5. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein. Behloul N; Baha S; Shi R; Meng J Virus Res; 2020 Sep; 286():198058. PubMed ID: 32531235 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651 [TBL] [Abstract][Full Text] [Related]
7. Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV. Letko M; Munster V bioRxiv; 2020 Jan; ():. PubMed ID: 32511294 [TBL] [Abstract][Full Text] [Related]
8. Structural basis of receptor recognition by SARS-CoV-2. Shang J; Ye G; Shi K; Wan Y; Luo C; Aihara H; Geng Q; Auerbach A; Li F Nature; 2020 May; 581(7807):221-224. PubMed ID: 32225175 [TBL] [Abstract][Full Text] [Related]
9. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites. Qiao B; Olvera de la Cruz M ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Datta PK; Liu F; Fischer T; Rappaport J; Qin X Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection. Tan HW; Xu YM; Lau ATY Rev Med Virol; 2020 Sep; 30(5):e2122. PubMed ID: 32602627 [TBL] [Abstract][Full Text] [Related]
12. Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins. Anand SP; Chen Y; Prévost J; Gasser R; Beaudoin-Bussières G; Abrams CF; Pazgier M; Finzi A Viruses; 2020 Sep; 12(10):. PubMed ID: 33003587 [TBL] [Abstract][Full Text] [Related]
13. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates. Damas J; Hughes GM; Keough KC; Painter CA; Persky NS; Corbo M; Hiller M; Koepfli KP; Pfenning AR; Zhao H; Genereux DP; Swofford R; Pollard KS; Ryder OA; Nweeia MT; Lindblad-Toh K; Teeling EC; Karlsson EK; Lewin HA Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22311-22322. PubMed ID: 32826334 [TBL] [Abstract][Full Text] [Related]
14. Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms. Ali A; Vijayan R Sci Rep; 2020 Aug; 10(1):14214. PubMed ID: 32848162 [TBL] [Abstract][Full Text] [Related]
15. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Ou X; Liu Y; Lei X; Li P; Mi D; Ren L; Guo L; Guo R; Chen T; Hu J; Xiang Z; Mu Z; Chen X; Chen J; Hu K; Jin Q; Wang J; Qian Z Nat Commun; 2020 Mar; 11(1):1620. PubMed ID: 32221306 [TBL] [Abstract][Full Text] [Related]
16. Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction. Witkowska D Molecules; 2020 Sep; 25(18):. PubMed ID: 32927621 [TBL] [Abstract][Full Text] [Related]
17. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Yang J; Petitjean SJL; Koehler M; Zhang Q; Dumitru AC; Chen W; Derclaye S; Vincent SP; Soumillion P; Alsteens D Nat Commun; 2020 Sep; 11(1):4541. PubMed ID: 32917884 [TBL] [Abstract][Full Text] [Related]
18. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein. Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194 [TBL] [Abstract][Full Text] [Related]